June 24 - 26, 2025
The Westin Copley Place, Boston, MA
This year's conference highlighted the rapid evolution of omnichannel strategies, as well as pharma organizations' efforts to break down silos to create better relationships with patients and customers. AI advancements, though still early, also showed promise for practical, compliant applications. Central to all discussions were patients, caregivers, communities, and HCPs, with pharma leaders discussing new methods for achieving meaningful interactions. Future Pharma is dedicated to fostering a community passionate about enhancing experiences for customers and patients. Below, you'll discover the key themes of the conference, as well as actionable insights you can apply to your own business strategies. We hope this report inspires and guides your organization's journey toward a healthier future.
In this article we cover: key focus areas for pharma to realistically advance data-driven strategies, the pharma marketing landscape: key trends impacting the industry, pharma's evolving approach and persistent challenges to data-driven marketing, and Underscore's value as a pharma marketing partner.
Pharma regulatory technology has come a long way from paper chaos to digital efficiency. Today’s strict rules and complex data present both challenges and opportunities for innovation. AI is set to revolutionize compliance by automating tasks, analyzing big data, and predicting issues, making the process smarter, faster, and easier.
Snake oil, anyone? Believe it or not, there was a time when those who manufactured patent “medicines” were completely unregulated. They could market their product directly to patients making any claim they wished, without any safety information, and without any repercussions. Crazy, but true! Thus, the birth of the proverbial term “snake oil,” which is, according to the Oxford English Dictionary, “a quack remedy or panacea.” Luckily, we’ve come a long way over the past 150 years…
With many in the industry now bouncing back from the challenges of the COVID-19 pandemic, we are seeing an increasing number of brands overhauling their marketing strategies to best succeed in this reformed landscape. In this case study, we examine how Sanofi is transforming its branding and marketing to move forwards from the crisis.
The fundamentals of pharma marketing have changed. Brands can no longer differentiate themselves through innovative product development alone. Instead, they must also differentiate themselves by understanding the needs of patients and their physicians, and by marketing based on context. This report explores how pharmaceutical companies are shifting their product marketing strategies from product-focused to audience-focused.